FDA Issues Highest Risk Recall for Ready Mental Clarity Capsules Over Undeclared Ingredients

The U.S. Food and Drug Administration (FDA) has issued its highest level of recall classification for Ready mental clarity capsules after laboratory testing identified several undeclared ingredients that may pose serious health risks. The action highlights growing concerns about dietary supplements marketed for cognitive performance, energy, and mood enhancement.

The recall applies to all lots of Ready capsules distributed nationwide through online sales between April 2022 and Dec. 8, 2025. According to the FDA, the affected product contained ingredients that were not disclosed on the product label, prompting regulators to classify the recall as a Class I recall, the agency's most serious category.

Why the FDA Issued the Recall

The FDA reported that regulatory testing found three undeclared substances in Ready capsules:

• Tianeptine
• 1,4-DMAA
• Aniracetam

Because these ingredients were not listed on the product label, consumers may have unknowingly consumed substances that could carry significant health risks.

The recall was initially announced in January, but the FDA has now elevated the action to a Class I recall following its review of the potential dangers associated with the product.

What Is a Class I Recall?

A Class I recall is the FDA's highest risk classification. It is issued when there is a reasonable probability that using or being exposed to a product could result in serious adverse health consequences or death.

The FDA also uses two lower recall categories:

• Class II: Products that may cause temporary or medically reversible health problems.
• Class III: Products that violate FDA regulations but are unlikely to cause adverse health effects.

The Class I designation underscores the seriousness of the agency's concerns regarding Ready capsules.

Health Risks Linked to the Undeclared Ingredients

Tianeptine

According to the FDA, tianeptine has been associated with severe health risks, including life threatening complications in certain individuals.

The agency warns that tianeptine may contribute to suicidal thoughts or behavior in children, adolescents, and adults aged 25 years and younger. It also cautions that combining tianeptine with monoamine oxidase inhibitor (MAOI) antidepressants may increase the risk of severe complications, including stroke and death.

1,4-DMAA

The FDA states that 1,4-DMAA may increase blood pressure and contribute to serious cardiovascular problems.

Potential complications include:

• Heart attack
• Shortness of breath
• Chest tightness
• Elevated blood pressure

These risks may become even more significant for individuals with underlying heart conditions or those taking other stimulant products.

Aniracetam

The FDA enforcement report identified aniracetam as another undeclared ingredient in the recalled capsules. Although marketed in some countries as a nootropic compound, it is not approved by the FDA for use in dietary supplements in the United States.

Consumers may not expect to ingest such substances when purchasing products labeled as natural supplements, making accurate labeling an important consumer safety issue.

Product Distribution Details

The recalled Ready capsules were distributed nationwide through online sales by Modern Warrior Life, a company based in Scottsdale, Arizona.

According to the FDA, affected products were sold from April 2022 until Dec. 8, 2025.

Anyone who purchased Ready capsules during that period should verify whether they possess the recalled product.

Company's Response

Modern Warrior Life stated that it has taken several actions following the recall.

According to the company's announcement, it has:

• Stopped distributing the product.
• Removed Ready capsules from sale.
• Quarantined remaining inventory.
• Advised consumers to stop using the product immediately.

The company also indicated that distribution has ceased while the recall process continues.

Ready Capsules Were Part of a Three Step Supplement Program

Before the recall, Ready capsules were sold as part of Modern Warrior Life's Body Repair Plan (BRP), which also included two additional supplements called Reset and Realign.

The company marketed the three products with various wellness claims.

According to promotional materials previously available on the company's website:

• Ready was promoted as supporting sustained energy and mood.
• Reset was advertised as helping optimize thyroid function and metabolism.
• Realign was marketed as supporting cortisol balance and testosterone regulation.

The complete Body Repair Plan previously sold for approximately $169.99.

The Ready product is no longer available for purchase through the company's website.

What Consumers Should Do

Consumers who have purchased Ready capsules should stop using the product immediately.

Individuals who experience unusual symptoms after taking the supplement should contact their healthcare provider as soon as possible. Anyone taking prescription medications, especially antidepressants or cardiovascular medications, should discuss any concerns with a medical professional.

Consumers should also monitor FDA recall announcements for additional information regarding dietary supplements and other health products.

Growing Concerns About Dietary Supplements

The recall serves as another reminder that dietary supplements are regulated differently from prescription medications.

Although many supplements are marketed for cognitive performance, weight management, or energy support, experts continue to encourage consumers to exercise caution, particularly when products promise dramatic health benefits.

Undeclared pharmaceutical ingredients remain one of the FDA's major concerns because they can expose consumers to unexpected drug interactions, allergic reactions, or serious medical complications.

Reading product labels carefully, purchasing from reputable manufacturers, and discussing supplements with healthcare providers may help reduce potential risks.

FDA Continues Monitoring Product Safety

The FDA routinely conducts inspections, laboratory testing, and post market surveillance to identify products that may present safety concerns.

When undeclared ingredients or contamination are discovered, the agency may initiate recalls and assign classifications based on the potential health risks involved.

Consumers can stay informed by checking official FDA recall notices and safety alerts regularly.

As investigations continue, the Class I recall of Ready capsules highlights the importance of transparency in supplement labeling and the role of regulatory oversight in protecting public health.

Source

• NTD Television, published July 21, 2026.
• U.S. Food and Drug Administration (FDA) recall and enforcement information.

Disclaimer

This article is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. If you have used the recalled product or are experiencing health concerns, consult a qualified healthcare professional or contact your local healthcare provider promptly.